Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Moexiprilat
Drug ID BADD_D01486
Description The active metabolite of the prodrug [Moexipril].
Indications and Usage Not Available
Marketing Status experimental
ATC Code Not Available
DrugBank ID DB14210
KEGG ID Not Available
MeSH ID C059506
PubChem ID 55331
TTD Drug ID D0R6KV
NDC Product Code Not Available
UNII H3753190JS
Synonyms moexiprilat | 2-(2-(1-carboxy-3-phenylpropyl)amino-1-oxopropyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | RS 10029 | RS-10029 | moexiprilat, (3S-(2(S*(R*)),3R*))-isomer | moexiprilat, (3R-(2(S*(S*)),3R*))-isomer | moexiprilat, (3S-(2(R*(S*)).3R*))-isomer
Chemical Information
Molecular Formula C25H30N2O7
CAS Registry Number 103775-14-0
SMILES CC(C(=O)N1CC2=CC(=C(C=C2CC1C(=O)O)OC)OC)NC(CCC3=CC=CC=C3)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Shock24.06.02.002--Not Available
Sinusitis22.07.03.007; 11.01.13.005--
Sleep disorder19.02.04.001--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Syncope02.11.04.015; 24.06.02.012; 17.02.04.008--
Tension19.06.02.005--Not Available
Tinnitus04.04.01.002; 17.04.07.004--
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Urticaria23.04.02.001; 10.01.06.001--
Vomiting07.01.07.003--
Acute coronary syndrome24.04.04.011; 02.02.02.015--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Affect lability19.04.01.001--Not Available
Ill-defined disorder08.01.03.049--Not Available
Renal impairment20.01.03.010--Not Available
The 3th Page    First    Pre   3    Total 3 Pages